Vaccines and Disease-Modifying Antirheumatic Drugs: Practical Implications for the Rheumatologist

Marcia A. Friedman, Kevin L. Winthrop

Research output: Contribution to journalReview articlepeer-review

52 Scopus citations


Patients with rheumatoid arthritis are highly vulnerable to infections because of abnormalities in their immune system, and because of immunosuppressive effects of their medications. Vaccinations in this population are complicated by disease-modifying antirheumatic drugs, which also modulate or suppress the immune system and potentially decrease the immunogenicity and efficacy of the vaccines. We review the available data regarding the impact of rheumatoid arthritis therapy on the immunogenicity of various common vaccines. We also review rheumatoid arthritis–specific vaccination recommendations, live vaccine safety concerns, and current gaps in our understanding of these issues.”

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalRheumatic Disease Clinics of North America
Issue number1
StatePublished - Feb 1 2017


  • Anti-TNF
  • Biologic
  • Efficacy
  • Immunogenicity
  • Rheumatoid arthritis
  • Rituximab
  • Vaccine

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Vaccines and Disease-Modifying Antirheumatic Drugs: Practical Implications for the Rheumatologist'. Together they form a unique fingerprint.

Cite this